Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review)

Basso Ricci,Sante; Cerchiari,Ugo

doi:10.3892/ol.2010.176

Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review)

Authors:
- Sante Basso Ricci
- Ugo Cerchiari
View Affiliations

Affiliations: Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy, Medical Physics Service, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Published online on: September 23, 2010 https://doi.org/10.3892/ol.2010.176
Pages: 941-946

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has been established that malignant tumors as well as metastases, of almost all histological types, can regress spontaneously although certain histological types regress more frequently than others. Various causes thereof include apoptosis, the immune system and particular conditions of the tumor microenvironment. The action of the genome in the regression of tumors is not clear, but some data, apart from those of apoptosis, support its involvement. The hypothesis that the immune system exhibits variations in efficacy, even to a marked extent, in determining partial or total regression of tumors appears to be plausible. Such variable efficacy may be supported by blockage of growth and the proliferation of cancer cells at the level of the tumor microenvironment, the intervention of various factors such as inhibitors of metalloproteinases and angiogenesis, and the absence or scarcity of particular proteins. The consequence of such a blockage would be a relative increase in the number of natural killer cells and other elements involved in the immune system in relation to the number of circulating cancer cells in the blood. A relative increase in the number of elements of the immune system is more effective than an absolute increase, since an absolute increase is able to stimulate, as frequently occurs for feedback in biological equilibria, inhibitor receptors that reduce the efficacy of the same elements (mainly natural killer and CD8+ T cells). Such an increase in the efficacy of the immune system can lead, at least in certain cases, to the so‑called spontaneous regression of malignant tumors. Clinical practice has demonstrated that metastases are less frequent in patients with renal carcinoma undergoing hemodialysis compared with patients with renal carcinoma not on hemodialysis. This finding can be interpreted, in correlation with the blockage of cancer cells in tissues, as a consequence of a partial blockage of metastatic cancer cells at the level of the dialytic membrane, with a subsequent increase in the relative efficacy of the immune system.

View Figures

View References

1	Chen Y, Takita J, Choi YL, et al: Oncogenic mutations of ALK kinase in neuroblastoma. Nature. 455:971–974. 2008. View Article : Google Scholar : PubMed/NCBI
2	Aoyama M, Ozaki T, Inuzuka H, et al: LMO3 interacts with neuronal transcription factor HEN2 and acts as an oncogene in neuroblastoma. Cancer Res. 65:4587–4597. 2005. View Article : Google Scholar : PubMed/NCBI
3	Munirajan AK, Ando K, Mukai A, et al: KIF1B(beta) functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem. 283:24426–24434. 2008. View Article : Google Scholar : PubMed/NCBI
4	Huang TW, Chen YL, Chen JC, Tsai WC, Chang H and Lee SC: Spontaneous regression of a mediastinal thymoma. J Thorac Cardiovasc Surg. 137:1277–1278. 2009. View Article : Google Scholar : PubMed/NCBI
5	Balzer BL and Ulbright TM: Spontaneous regression of testicular germ cell tumors. An analysis of 42 cases. Am J Surg Pathol. 30:858–865. 2006. View Article : Google Scholar : PubMed/NCBI
6	Printz C: Spontaneous regression of melanoma may offer insight into cancer immunology. J Natl Cancer Inst. 93:1047–1048. 2001. View Article : Google Scholar : PubMed/NCBI
7	Li AJ, Wu MC, Cong WM, Shen F and Yi B: Spontaneous complete necrosis of hepatocellular carcinoma: a case report. Hepatobiliary Pancreat Dis Int. 2:152–154. 2003.PubMed/NCBI
8	Basso Ricci S, Coradini D, Di Fronzo G, Bartoli C and Villa S: Estrogen receptor status of patients subjected to mastectomy for breast cancer with a disease-free interval of no less than 8 years. Am J Clin Oncol. 21:250–252. 1998.PubMed/NCBI
9	Basso Ricci S: Letter to the editor. Med Hypothesis. 64:428–431. 2005.
10	Reed JC: Balancing cell life and death. Bax, apoptosis, and breast cancer. J Clin Invest. 97:2403–2404. 1996. View Article : Google Scholar : PubMed/NCBI
11	Teixeira C, Reed JC and Pratt MAC: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:3902–3912. 1995.PubMed/NCBI
12	Wang TTY and Phang JM: Effects of estrogen on apoptosis pathways in human breast cancer cell line MCF-7. Cancer Res. 55:2487–2489. 1995.PubMed/NCBI
13	Dikinson RB and Lipman ME: Growth regulation of normal and malignant breast epithelium. The Breast: Comprehensive Management of Benign and Malignant Diseases. 2nd edition. 1. Bland K and Copeland EM III: WB Saunders; Philadelphia: pp. 5181998
14	Lederman GS, Niloff JM, Redline R and Rosen EM: Late recurrence in endometrial carcinoma. Cancer. 59:825–828. 1987. View Article : Google Scholar : PubMed/NCBI
15	Tubiana N, Schlumberger M, Rougier P, et al: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 55:794–804. 1985. View Article : Google Scholar : PubMed/NCBI
16	Van den Ouden D, Hop WC and Schröder FH: Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol. 160:1392–1397. 1998.PubMed/NCBI
17	Wang XW: Role of p53 and apoptosis in carcinogenesis. Anticancer Res. 19:4759–4771. 1999.PubMed/NCBI
18	Navratil JS, Liu CC and Ahearn JM: Apoptosis and autoimmunity. Immunol Res. 36:3–12. 2006. View Article : Google Scholar
19	Yamashita Y, Kumabe T, Shimizu H, Ezura H and Tominaga T: Spontaneous regression of a primary cerebral tumor following vasospasm caused by subarachnoid hemorrhage due to rupture of an intracranial aneurism. A case report. Neurol Med Chir. 4:187–190. 2004. View Article : Google Scholar
20	Wu J and Lanier LL: Natural killer cells and cancer. Adv Cancer Res. 90:127–156. 2003. View Article : Google Scholar
21	Lanier LL, Corliss BC, Wu J, Leong C and Phillips JH: Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:703–707. 1998. View Article : Google Scholar : PubMed/NCBI
22	Lanier LL, Yu G and Phillips JH: Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 142:803–805. 1989. View Article : Google Scholar : PubMed/NCBI
23	Brooks AG, Posch PE, Scorzelli CT, Borrego F and Coligan JE: NKG2A complexed with CD94 defines a novel inhibitory natural kill cell receptor. J Exp Med. 185:795–800. 1997. View Article : Google Scholar : PubMed/NCBI
24	Lanier LL: Natural killer cell receptor signaling. Curr Opin Immunol. 15:308–314. 2003. View Article : Google Scholar : PubMed/NCBI
25	Munshi HG and Stack MS: Reciprocal interaction between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 25:45–56. 2006. View Article : Google Scholar : PubMed/NCBI
26	Hood JD and Cheresh DA: Role of integrins in cell invasion and migration. Natl Rev Cancer. 2:91–100. 2002. View Article : Google Scholar : PubMed/NCBI
27	Hoskin DH, Mader JS, Furlong SJ, Conrad DM and Blay J: Inhibition of T-cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int J Oncol. 18:527–535. 2008.PubMed/NCBI
28	Kurita M, Hirano K, Ebihara S, et al: Spontaneous regression of cervical lymph node metastasis in patients with mesopharyngeal squamous cell carcinoma of the tongue: possible association between apoptosis and tumor regression. Int J Clin Oncol. 12:448–454. 2007. View Article : Google Scholar
29	Thoroddsen A, Geirsson G, Agnarsson BA and Magnusson K: Spontaneous regression of pleural metastases after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol. 5:396–398. 2002. View Article : Google Scholar : PubMed/NCBI
30	DeWeerd JH, Hawthorne J and Adson MA: Regression of renal cell hepatic metastases following removal of primary lesions. J Urol. 117:790–792. 1977.PubMed/NCBI
31	Basso Ricci S: Dialysis membrane and metastatic cancer cells. Clin Nephrol. 68:354–356. 2007.